Document Detail

Comparison of single-dose moxalactam and a three-dose regimen of cefoxitin for prophylaxis in vaginal hysterectomy.
MedLine Citation:
PMID:  3542346     Owner:  NLM     Status:  MEDLINE    
In patients undergoing vaginal hysterectomy, prophylactic use of a single dose of moxalactam was compared with use of a standard three-dose regimen of cefoxitin for efficacy and for rate of postoperative colonization of the vaginal cuff with resistant bacteria. In a prospective, randomized study, patients hospitalized for vaginal hysterectomy received either cefoxitin sodium 2 g intramuscularly on call to the operating room followed by 2 g intravenously every six hours for two additional doses or a single dose of moxalactam disodium 2 g intramuscularly on call. Cultures of the meatal area and of urine were obtained preoperatively; postoperatively, cultures of urine, of the vaginal cuff, and of any site or fluid presumed to be infected were obtained. Data were evaluated for 38 patients in the moxalactam group and 40 patients in the cefoxitin group. There was no significant difference in the incidence of infectious morbidity (7.5% of cefoxitin-treated patients and 10.5% of moxalactam-treated patients). Infectious morbidity was not related to age, length of surgery, or estimated blood loss. The incidence of febrile morbidity was not significantly different (7.5% of the cefoxitin group and 13.2% of the moxalactam group). Colonization of the vaginal cuff with resistant organisms occurred in 70% of cefoxitin patients and 71% of moxalactam patients and was a poor predictor of infectious morbidity. In these 78 women undergoing vaginal hysterectomy, single-dose moxalactam and a three-dose regimen of cefoxitin were equally effective for surgical prophylaxis.
R P Rapp; J E Connors; W D Hager; E S Donaldson; J R van Nagell
Related Documents :
8575686 - Clinical, hormonal and sonographic predictors of successful ru-486-induced abortions.
12113966 - Induction of labor with prostaglandin e2 vaginal tablets in parous and grandmultiparous...
7890256 - Ritodrine tocolysis and neonatal intraventricular-periventricular hemorrhage.
25301436 - Incidence of and risk factors for postoperative urinary retention in fast-track hip and...
7457696 - Revision of gastric bypass.
23515986 - Arthroscopic treatment of osteochondral defects of the talus: outcomes at eight to twen...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical pharmacy     Volume:  5     ISSN:  0278-2677     ISO Abbreviation:  Clin Pharm     Publication Date:  1986 Dec 
Date Detail:
Created Date:  1987-03-24     Completed Date:  1987-03-24     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8207437     Medline TA:  Clin Pharm     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  988-93     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bacteria, Aerobic / drug effects
Bacteria, Anaerobic / drug effects
Cefoxitin / therapeutic use*
Clinical Trials as Topic
Hysterectomy, Vaginal*
Microbial Sensitivity Tests
Middle Aged
Moxalactam / therapeutic use*
Random Allocation
Surgical Wound Infection / microbiology,  prevention & control*
Reg. No./Substance:
35607-66-0/Cefoxitin; 64952-97-2/Moxalactam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Short-course drug therapy for tuberculosis.
Next Document:  Lyme disease.